Home

Viking Global Equities LP

CIK 1101785 · last filed 2019-06-03

Viking Global Equities LP is a corporate insider who has filed 4 SEC Form 4 insider transactions across 3 companies since 2014. The most recent filing shows the insider bought $1.4M of UROV on Jun 3, 2019. Across all open-market trades the lifetime net is +$3.0M, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $186.5M across reported positions. The firm reports its address in Stamford, CT. 32 SEC filings were submitted jointly with Viking Global Equities II LP.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$186.46M

Companies

3

Total Filings

4

Lifetime Open-Market Net

$3.02M

Filer Profile

Reported Address
600 WASHINGTON BOULEVARD
11TH FLOOR
STAMFORD, CT 06901
Phone
(203) 863-5000
State of Incorporation
DE
Related Filers
Viking Global Equities II LP — 32 joint filings, latest 2019-07-12
VIKING GLOBAL PERFORMANCE LLC — 30 joint filings, latest 2019-07-12
Viking Long Fund GP LLC — 30 joint filings, latest 2019-07-12
Viking Long Fund Master Ltd. — 30 joint filings, latest 2019-07-12
OLE ANDREAS HALVORSEN — 18 joint filings, latest 2019-07-12
David C. Ott — 18 joint filings, latest 2019-07-12
Rose Sharon Shabet — 16 joint filings, latest 2019-07-12
Viking Global Equities Master Ltd. — 15 joint filings, latest 2019-07-12
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Urovant Sciences Ltd. (UROV) Delisted 10%+ Owner 22,766,543 $16.24 $369.73M $3.02M 2 2019-06-03
EDIT 2,966,387 $3.03 $8.99M $0 1 2016-02-09
W 10%+ Owner 1,775,290 $99.97 $177.48M $0 1 2014-10-06

Recent Filings

4 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2019-06-03 Urovant Sciences Ltd. (UROV) Delisted Buy (P) +177,460 $1.39M EDGAR
2019-05-23 Urovant Sciences Ltd. (UROV) Delisted Buy (P) +198,300 $1.63M EDGAR
2016-02-09 EDIT Mixed +32,757,696 $0 EDGAR
2014-10-06 W Buy (P) +1,754,133 $0 EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.